Middle East respiratory syndrome coronavirus infection physical examination
Middle East Respiratory Syndrome Coronavirus Infection Microchapters |
Differentiating Middle East Respiratory Syndrome Coronavirus Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Middle East respiratory syndrome coronavirus infection physical examination On the Web |
American Roentgen Ray Society Images of Middle East respiratory syndrome coronavirus infection physical examination |
FDA on Middle East respiratory syndrome coronavirus infection physical examination |
CDC on Middle East respiratory syndrome coronavirus infection physical examination |
Middle East respiratory syndrome coronavirus infection physical examination in the news |
Blogs on Middle East respiratory syndrome coronavirus infection physical examination |
Directions to Hospitals Treating Middle East respiratory syndrome coronavirus infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Patients with MERS-CoV infection typically present with vital signs derangement, such as high-grade fever, tachycardia, tachypnea, and decreased oxygen saturation. Signs on physical examination may include decreased breath sounds, crackles, dullness on percussion, and increased tactile fremitus on pulmonary auscultation. Signs of complications may also be present, such as profound hypotension (suggestive of shock) or pericardial rub (suggestive of pericarditis).[1][2][3]
Physical Examination
Typical signs on physical examination for MERS-CoV primary infection are shown below. Additionally, signs for MERS-CoV-associated complications may also be present.
General Appearance
Vital Signs
- Hypotension
- Tachycardia
- Tachypnea
- Fever (typically high-grade)
- Decreased oxygen saturation
HEENT
- Tonsillar swelling
Cardiothoracic
- Stridor
- Decreased breath sounds
- Crackles, rhonchi, wheezing on pulmonary auscultation
- Dullness on thoracic percussion
- Increased tactile fremitus
- High intensity egophony
References
- ↑ Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J; et al. (2014). "Repurposing of clinically developed drugs for treatment of Middle East Respiratory Coronavirus Infection". Antimicrob Agents Chemother. doi:10.1128/AAC.03036-14. PMID 24841273.
- ↑ "Clinical management of severe acute respiratory infections when novel coronavirus is suspected: What to do and what not to do" (PDF).
- ↑ 3.0 3.1 "MERS Prevention and Treatment".
- ↑ Memish, Ziad A.; Zumla, Alimuddin I.; Assiri, Abdullah (2013). "Middle East Respiratory Syndrome Coronavirus Infections in Health Care Workers". New England Journal of Medicine. 369 (9): 884–886. doi:10.1056/NEJMc1308698. ISSN 0028-4793.